Biocryst Pharmaceuticals reported $304.16M in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Adamas Pharmaceuticals ADMS:US 129.04M 671K
Alexion Pharmaceuticals ALXN:US $ 2532M 30M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Biocryst Pharmaceuticals BCRX:US $ 304.16M 10.51M
Chemocentryx CCXI:US $ 23.57M 0.98M
Daiichi Sankyo 4568:JP Y 163647M 20092M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0.03M
GlaxoSmithKline GSK:LN 25605M 122M
Glaxosmithkline GSK:US $ 25605M 122M
Intra Cellular Therapies ITCI:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 1303M 7.54M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Mirati Therapeutics MRTX:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Novavax NVAX:US $ 427.09M 3.23M
Ptc Therapeutics PTCT:US $ 1176.77M 14.94M
Regeneron Pharmaceuticals REGN:US $ 2698.6M 1M
Sarepta Therapeutics SRPT:US $ 1094.91M 1.93M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 513.26M 11.67M
YTE INCY:US $ 33.78M 0.47M
Zogenix ZGNX:US $ 155.87M 2.24M